| A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) (NCT07455045) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2026-03-01 |
| A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT (NCT05171894) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2024-09-21 |
| FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer (NCT06519370) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2024-08-09 |
| A Study of FZ-AD005 in Patients With Advanced Solid Tumors (NCT06424665) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2024-07-03 |
| Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA） (NCT06417281) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2024-06-19 |
| A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors (NCT06413615) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2024-05-13 |
| A Study of FZ-AD004 in Patients With Advanced Solid Tumors (NCT05914545) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2023-06-12 |
| A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors (NCT05564858) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2023-01-16 |
| A Study of FDA018-ADC in Patients With Advanced Solid Tumors (NCT05174637) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2021-10-22 |
| Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis (NCT06715319) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2021-10-09 |
| ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection (NCT06439433) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2021-05-31 |
| Phase 1 Study to Evaluate Safety and Pharmacokinetics of FZJ-003 in Healthy Volunteers (NCT04715529) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2021-01-27 |
| Pharmacokinetics and Safety of ALA in Acne Vulgaris (NCT04044898) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2021-01-12 |
| A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain (NCT04106258) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2020-05-27 |
| A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris (NCT04018885) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2019-07-11 |
| A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies. (NCT03894150) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2019-04-11 |
| Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain (NCT03181984) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2017-08-31 |
| A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain (NCT03125057) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2017-08-02 |
| Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma (NCT02955771) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2017-05-17 |
| Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) (NCT02631863) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2016-03-22 |
| Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis) (NCT02481180) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2015-07-31 |
| Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia (NCT02304770) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2015-01-01 |
| Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers (NCT02291471) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2014-10-01 |
| Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer (NCT02237690) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2014-09-01 |
| Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers (NCT01481597) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2011-11-01 |